Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2016

01-03-2016 | Hepatobiliary Tumors

Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases

Authors: Giuseppe Zimmitti, MD, Jose Soliz, MD, Thomas A. Aloia, MD, Vijaya Gottumukkala, MD, Juan P. Cata, MD, Ching-Wei D. Tzeng, MD, Jean-Nicolas Vauthey, MD

Published in: Annals of Surgical Oncology | Issue 3/2016

Login to get access

Abstract

Introduction

Previous studies have suggested that the use of regional anesthesia can reduce recurrence risk after oncologic surgery. The purpose of this study was to assess the effect of epidural anesthesia on recurrence-free (RFS) and overall survival (OS) after hepatic resection for colorectal liver metastases (CLM).

Methods

After approval of the institutional review board, the records of all adult patients who underwent elective hepatic resection between January 2006 and October 2011 were retrospectively reviewed. Patients were categorized according to use of perioperative epidural analgesia versus intravenous analgesia. Univariate and multivariate analyses were performed to identify factors influencing RFS and OS.

Results

Of 510 total patients, 390 received epidural analgesia (EA group) and 120 patients received intravenous analgesia (IVA group). Compared with the IVA group, more patients in the EA group underwent associated surgical procedures with consequently longer operative times (p < 0.001). In addition, the EA group received more intraoperative fluids and had higher urine output volumes (p ≤ 0.001). Five-year RFS was longer in the EA group (34.7 %) compared with the IVA group (21.1 %). On multivariate analysis, the receipt of epidural analgesia was an independent predictor of improved RFS (p = 0.036, hazard ratio [HR] 0.74; 95 % confidence interval [CI] 0.56–0.95), but not OS (p = 0.102, HR 0.72; 95 % CI 0.49–1.07).

Conclusions

This study suggests an association between epidural analgesia and improved RFS, but not OS, after CLM resection. These results warrant further prospective, randomized studies on the benefits of regional anesthesia on oncologic outcomes after hepatic resection for CLM.
Literature
1.
Lau WY, Lai EC Hepatic resection for colorectal liver metastases. Singapore Med J. 2007;48(7):635–9.PubMed
2.
Koshariya M, Jagad RB, Kawamoto J, et al. An update and our experience with metastatic liver disease. Hepatogastroenterology. 2007;54(80):2232–9.PubMed
3.
Tavare AN, Perry NJ, Benzonana LL, et al. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer. 2011;130(6)1237–50.CrossRefPubMed
4.
De Oliveira GS Jr, Schink JC, Buoy C, et al. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfus Med. 2012;22(2):97–103.CrossRefPubMed
5.
Cata JP, Wang H, Gottumukkala V, et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701.PubMedCentralCrossRefPubMed
6.
Gottschalk A, Sharma S, Ford J, et al. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110(6):1636–43.CrossRefPubMed
7.
Unic-Stojanovic D, Babic S, Jovic M Benefits, risks and complications of perioperative use of epidural anesthesia. Medicinski Arhiv. 2012;66(5):340–3.CrossRefPubMed
8.
Manion SC, Brennan TJ Thoracic epidural analgesia and acute pain management. Anesthesiology. 2011;115(1):181–8.CrossRefPubMed
9.
Liu SS, Wu CL Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence. Anesth Analg. 2007;104(3):689–702.CrossRefPubMed
10.
Rigg JR, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359(9314):1276–82.CrossRefPubMed
11.
Capmas P, Billard V, Gouy S, et al. Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer. Anticancer Res. 2012;32(4):1537–42.PubMed
12.
Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ. 2011;342:d1491.CrossRefPubMed
13.
Tsui BC, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth. 2010;57(2):107–12.CrossRefPubMed
14.
Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113(1):27–34.CrossRefPubMed
15.
Chang SB, Palavecino M, Wray CJ, et al. Modified Makuuchi incision for foregut procedures. Arch Surg. 2010;145(3):281–4.CrossRefPubMed
16.
Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351–5.CrossRefPubMed
17.
Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333-39. HPB (Oxford). 2002;4(2):99; author reply 99–100.CrossRef
18.
Blazer DG, 3rd, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26(33):5344–51.CrossRefPubMed
19.
Shindoh J, Loyer EM, Kopetz S, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30(36):4566–72.PubMedCentralCrossRefPubMed
20.
Brouquet A, Zimmitti G, Kopetz S, et al. Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases. Cancer. 2013;119(15):2778–88.PubMedCentralCrossRefPubMed
21.
Dindo D, Demartines N, Clavien PA Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.PubMedCentralCrossRefPubMed
22.
Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18.PubMedCentralCrossRefPubMed
23.
24.
Sessler DI Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev. 2008;17(3):269–72.CrossRefPubMed
25.
Beilin B, Shavit Y, Trabekin E, et al. The effects of postoperative pain management on immune response to surgery. Anesth Analg. 2003;97(3):822–7.CrossRefPubMed
26.
Shavit Y, Lewis JW, Terman GW, et al. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science. 1984;223(4632):188–90.CrossRefPubMed
27.
Singleton PA, Moss J Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010;6(8):1237–42.CrossRefPubMed
28.
Welden B, Gates G, Mallari R, Garrett N Effects of anesthetics and analgesics on natural killer cell activity. AANA J. 2009;77(4):287–92.PubMed
29.
30.
Warschkow R, Steffen T, Luthi A, et al. Epidural analgesia in open resection of colorectal cancer: is there a clinical benefit? a retrospective study on 1,470 patients. J Gastrointest Surg. 2011;15(8):1386–93.CrossRefPubMed
31.
Biki B, Mascha E, Moriarty DC, et al. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109(2):180–7.CrossRefPubMed
32.
Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology. 2012;116(4):797–806.CrossRefPubMed
33.
Gupta A, Bjornsson A, Fredriksson M, et al. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth. 2011;107(2):164–70.CrossRefPubMed
34.
Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth. 2010;105(2):145–9.CrossRefPubMed
35.
Wuethrich PY, Hsu Schmitz SF, Kessler TM, et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology. 2010;113(3):570–6.PubMed
36.
Binczak M, Tournay E, Billard V, et al. Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival? Ann Fr Anesth Reanim. 2013;32(5):e81–8.CrossRefPubMed
37.
Holler JP, Ahlbrandt J, Burkhardt E, et al. Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): an analysis of a cancer registry. Ann Surg. 2013;258(6):989–93.CrossRefPubMed
Metadata
Title
Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases
Authors
Giuseppe Zimmitti, MD
Jose Soliz, MD
Thomas A. Aloia, MD
Vijaya Gottumukkala, MD
Juan P. Cata, MD
Ching-Wei D. Tzeng, MD
Jean-Nicolas Vauthey, MD
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4933-1

Other articles of this Issue 3/2016

Annals of Surgical Oncology 3/2016 Go to the issue

Breast Oncology

Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment

Gynecologic Oncology

Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis

Breast Oncology

Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy

Breast Oncology

Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor

Hepatobiliary Tumors

Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study

Colorectal Cancer

Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer